Pre-eclampsia (PE) is a major cause of maternal and prenatal morbidity and mortality in developing countries. PE occurs in about 6% of the general women population. It complicates about 5-15% of pregnancies over 20 weeks and is responsible for 16% of maternal mortality. Pre-delivery serum Ferritin concentration was signi cantly higher in patients with eclampsia than in healthy pregnant women. e serum ferritin was the best sensitive marker of the iron status parameters re ecting the preeclampsia. e aim of the study is to explore the association between serum ferritin and Preeclampsia and to do a comparison of serum ferritin to assess risk of development preeclampsia between case and control. is is a case-control study with laboratory methods. and the sample size was 80. A total of 80 pregnant women, comprising of 40 PE and 40 normotensive primi or multigravida in the third trimester were enrolled in the study. e mean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) were signi cantly higher in PE group on both occasions compared to normotensive women with similar chronological age *For corrcspondence gestational age. Out of the 40 cases 65% patients had severe proteinuria (+++) and 17.5% had moderate proteinuria (++) and 17.5% had mild proteinuria. e di erence between case and control with respect to proteinuria was highly signi cant. More than two third (67.5%) of the cases did not have any iron de ciency anemia, while the rest (32.5%) had mild iron de ciency anemia. In the present study, the mean serum Ferritin level of PE group was almost 10 times higher (167.11 ± 10.43 ngm/ml) than that of controls (17.0 ± 3.03 ngm/ml) than that of control (431.0 ± 10.93 gm/dl). More than one-third of the cases showed serum ferritin >210 ngm/ml, compared to none of the control group. Serum Ferritin level is signi cantly higher in preeclamptic patients than the control group.
INTRODUCTION
Preeclampsia (PE) is a hypertensive complication of pregnancy associated with well-documented risk for the mother and the fetus. Despite the advancement in the eld of medicine, preeclampsia/eclampsia still remains the third leading cause of maternal mortality. l It is a major cause of maternal and prenatal morbidity and mortality in developing countries.PE occurs in about 6% of the general population. It complicates about 5-15% of pregnancies over 20 weeks and is responsible for 16% of maternal mortality and 28% of prenatal mortality. 3 ough preeclampsia/eclampsia is a largely preventable condition and the incidence is decreasing in developed countries. Unfortunately, such cases still pose a great problem in developing countries like Bangladesh.
PE is hypertension associated with proteinuria and edema, occurring primarily in nulliparas after the week of gestation, most frequently near term. Hypertension and proteinuria are simple clinical criteria for the diagnosis of PE. Women with PE are at increased risk of complications such as abruptio placenta, acute renal failure, cerebral hemorrhage, disseminated intravascular coagulation, pulmonary edema, circulatory collapse, and eclampsia. 4 PE is a disease of multiple theories. Among them genetic, immunological, circulatory factors, uterovascular changes, and endothelial dysfunction are important. Despite extensive research, the mechanisms of underlying PE are yet to be de ned. 5 As pathogenesis is obscure, de nite preventive and curative measures are yet not possible.
Although exact etiology of PE is still unknown, results of past studies show that abnormal placentation plays a crucial role in its pathogenesis. In cases of pregnancies complicated with PE, not all the spiral arteries of the placental bed are invaded by trophoblast. ose arteries that are invaded, the rst phase of trophoblastic invasion occurs normally, but the second phase does not occur and the myometrial portions of the spiral arteries retain their reactive musculoelastic walls. 6 e qualitative and quantitative restriction of normal physiological changes results in restricted placental blood ow, which becomes more critical with advancing gestation as the demand of the conceptus increases. 7 In addition, acute atherosis develops in the myometrial segments of the spiral arteries. Acute atherosis may progress to vessel obliteration with corresponding areas of placental infarction. 8 Several independent investigators have demonstrated through studies that vascular endothelium provides a single target organ system involved in PE. e relatively new theory of endothelial injury explains many of the clinical ndings in PE. 9 e ischemic placenta are the cause of generalized endothelial cell damage that gives, rise to the symptoms of hypertension, proteinuria, and sudden edema characteristic of this condition. 10 It has been suggested that lipid peroxidation may play or role in the pathology of PE. 11 This high level of lipid hydroperoxides believed to be present in PE are among the candidate agents capable of causing such damage to the vascular euothelium. 12 Serum iron concentration was higher in patients with preeclampsia (mean of 135 ug/dl) compared to normotensive parturient (mean of 62 ug/dl) and chronic hypertensive parturient (mean of 72 ug/dl). Mean iron for patients with eclampsia was 203 ug/dl and 137 ug/dl) for patients with severe preeclampsia. A concomitant increase in serum Ferritin (mean of 59 ng/ml vs 19 ng/ml for normal) persisted longer. 13 Pre-delivery serum Ferritin concentration was signi cantly higher in patients with eclampsia than in healthy pregnant women. 14 e serum Ferritin was the best sensitive marker of the iron status parameters re ecting the preeclampsia and the result may support the role of iron as a catalyzer of oxidative stress and lipid peroxidation in the pathophysiology of preeclampsia. 15 Hyperferritinemia in patients with preeclampsia appears to be attributable to the combined e ects of increased Ferritin synthesis and the release of intracellular Ferritin from damaged cells. 16 Considering these facts, this study was designed to clarify the role of iron parameters in the pathogenesis of PE.
MATERIALS AND METHODS

Research design:
is is a case-control study with laboratory methods.
Place of study:
e study was carried out in the Department of Obstetrics and Gynaecology, Sir Salimullah Medical College and Hospital.Serum Ferritin was tested in the Department of Biochemistry, BSMMU.
Duration of study: e study was carried out from
January 2008 to December 2009 4. Study population: ere were 40 cases of preeclampsia and 40 normotensive pregnant women were enrolled from Sir Salimullah Medical College and Hospital, Dhaka. e normotensive pregnant women were taken as control.
Sampling and selection criteria: Purposive Sampling
technique.
6. Sample size: 80 samples.
Data Collection:
Inclusion criteria for a case are x Primigravid or multigravid women with blood pressure 140/90mmHg. is rise in blood pressure was observed at least on two occasions 6 hours apart.
x Urinary protein of 0.3gm/L or more and
x Single gestation.
Inclusion criteria for control are
x Normotensive primigravid or multigravid women matched for age and gestation with cases.
x Normal BP recording throughout pregnancy
x Urinary protein nil
x Single gestation Relevant clinical data were recorded in the predesigned data collection sheet.
Collection of blood sample: Maintaining all aseptic precautions, 6 ml of venous blood was drawn from the antecubital vein of each pregnant woman in the sitting position 2 ml of that blood was taken in EDTA tube for Hb% and peripheral blood lm. 4 ml of blood was immediately transferred into a clean, dry test tube and was centrifuged with 1 hour of collection. e serum thus obtained was stored at -70' C until assessed.
Laboratory methods x
Estimation of serum Ferritin by MEIA.
x Estimation of Hb% by Colorimetric method.
x Estimation of blood urea, serum creatinine, serum electrolyte, random blood sugar, serum bilirubin, SGPO, SGOT by the analyzer.
Procedure:
e AxSYM Ferritin reagents and sample is pipette in the following sequence.
Sample and AxSYM Ferritin reagent require for one test is pipette by the sampling probe into various wells of a reaction vessel (RV).
Sample is Pipetted into one well of the RV. Anti Ferritin coated microparticle, anti Ferritin alkaline phosphates conjugate, specimen diluents and TRIS bu er are pipetted into another well of a reaction vessel. e RV is immediately transferred to the processing center. Further pipetting is done in the processing center.
Estimation of Urinary protein:
About 5 ml or midstream random urine sample was collected in a clean and dry test tube. e reagent strip was dipped into the urine for making sure that all the reagent areas have contacted the urine specimen. e excess urine was removed by running the edge of the strip against the rim of the test tube and was held in horizontal position to prevent mixing of the chemical from adjacent reagent areas and to prevent contamination of hand with urine. en the strip was properly oriented near the appropriate color chart on the container label and read the results under good lighting. Urinary protein changes the color of the reagent strip from yellow to green.Urinary protein of 0.3 gm/l or more were considered as positive.
Data Processing & Analysis:
Data were processed and analyzed using computer software SPSS version 11.5
RESULTS
A total of 80 pregnant women, comprising of 40 PE and 40 normotensive primi or multigravida in the third trimester were enrolled in the study. Both the groups were matched for their chronological age and gestational age. e blood pressure was recorded on admission and 6 hours later. No signi cant di erences were found between cases and controls with respect to age, socioeconomic status, education, parity, gravidity, gestational age, and antenatal checkup. e means SD) SBP (mmHg) on admission was 155.25 ± 14.14 for PE and 103.25 ±8.29 for the control group and after 6 hours it was 145.75 ± 8.44 for PE and 99.75 ±6.20 for the control. e mean (± SD) DBP (mmHg) on the admission was 109.38 ±12.31 for PE and 68.00 ± 8.23 for the control group and after 6 hours it was 10.38 ±10.65 for PE and 65.25 7.51 for control. So the mean SBP and DBP were signi cantly higher in PE group on both occasions compared to normotensive women with similar chronological age gestational age (p<0.001). Of the 40 cases 65% patients had severe proteinuria (+++) and 17.5% had moderate proteinuria (++) and 17.5% had mild proteinuria.Whereas, none of the control groups had any degree of proteinuria. e di erence between case and control with respect to proteinuria was highly signi cant (p<0.001) More than two third (67.5%) of the cases did not have any iron de ciency anemia, while the rest (32.5%) had mild iron de ciency anemia. In contrast, 55% of the controls exhibited mild iron de ciency anemia. e mean hemoglobin level of cases was also revealed to be signi cantly higher (11.06 ± 1.15 gm/dl) than that of controls (8.9 ± 1.3 gm/dl) (p<0.001). (Table V) . e mean serum Ferritin level of cases was almost 10 times higher (167.11 +10.43 ngm/ml) than that of controls (17.0 + 3.03 ngm/ml) (p < 0.001) ( Table-IX ). More than one-third of the cases showed serum Ferritin >210 ngm/ml, compared to none of the control group (Table X) . 
Cases Control
DISCUSSION
Studies carried out in other countries also showed similar results. Margaret el al in their study reported similar results regarding serum Ferritin in the PE patients when compared to control group.T hey showed in their study showed that percent saturation of transferrin was signi cantly higher in PE patients than the control group. AST level was done as an indicator of liver damage. 17 Vaughan et al in their study also found that serum Ferritin was signi cantly higher in preeclamptic patients when compared to control group which is similar to the present study and they suggested that increased Ferritin levels may be responsible for placental oxidative stress and abnormalities in the antioxidants and thromboxane. ey found no signi cant correlation between serum iron, serum Ferritin, total iron binding capacity, percent saturation of total iron binding capacity and indices of hepatocellular injury (AST). 18 e study carried out by Vitoratos et al showed similar result regarding the mean serum Ferritin level in women with PE when compared to a matched control group (p<0.01 respectively). Vitoratos et al also found higher serum ceruloplasmin level compared to those control group (p<0.01), while the mean ferroxidase activity levels of ceruloplasmin did not di er signi cantly between PE group and control group.
is result indicates that the plasma of preeclamptic women declines the ferroxidase activity of ceruloplasmin and reduces total iron binding capacity. us it seems that the plasma of preeclamptic women lacks the protective antioxidative action of this substances. 19 Philip Samuel et al demonstrated a similar result regarding serum Hb% in the PE patient when compared to the control group. is observation con rms the ndings of Entman et a1. 20 Stephen et al reported similar results regarding mean (±SD) serum Ferritin concentrations among preeclamptic women compared to the control group. e mean (±SD) Ferritin level of patients with severe preeclampsia was also revealed to be signi cantly higher than that of patients with mild preeclampsia (p<0.02). 21 In the present study percent saturation of transferrin, serum AST, LDH, ceruloplasmin, malondialdehyde, and total bilirubin were not assessed but these parameters were studied by other investigators. In the present study, the risk of developing preeclampsia was found to be associated with abnormal serum Ferritin. e study revealed that elevated serum Ferritin increases the risk of developing preeclampsia among pregnant mothers by at least two-fold.
In spite of improvement of antenatal check up, PE still remains a major health problem in the eld of obstetrics both in developing countries like Bangladesh and in developed countries. It is the most important cause of maternal death in the USA, Scandinavia, Iceland, Finland and UK. 22 e etiology of PE is still unknown. Several studies are going on in this eld. e present study was designed to see the role of serum Ferritin in the pathophysiology of PE.
Philip Samuel et al observed the strongest correlations between serum iron, LDH, and plasma hemoglobin. A strong correlation was also observed between total bilirubin and serum iron concentration. Parameters of hepatocellular damage correlated poorly with serum iron (AST, p.008). LDH can originate from red blood cells or the liver and they did not have the ability to distinguish between these isoenzymes. So they suggested that this increase in iron arise from a mild, ongoing intracellular hemolysis. 23 Hubel et al observed an increased level of serum malondialdehyde in preeclamptic patients than those of the control group. In their study electron, paramagnetic resonance spectroscopy con rmed that total transferrin in PE patients was signi cantly lower and percent saturation of transferrin was higher in PE than those in control group. 24 
CONCLUSION
Higher Serum Ferritin level are associated with preeclampsia.
LIMITATION OF THE STUDY
e researchers faced several problems during the study:
x
Sample size is small
x All confounders could not be excluded
x Lack of fund and resource was a major problem of this study
x e study was con ned to a tertiary care hospital and so not represented the community. So, the results might not be generalized.
RECOMMENDATION
Further studies may be conducted in larger population including other parameters like serum AST, LDH, hemopexin, total bilirubin, transferrin and percent saturation of transferrin which may a ect the serum iron level in preeclampsia.
